Siltuximab in Schizophrenia

NCT02796859 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Brian Miller

Collaborators